Intellia Therapeutics Inc (NTLA)
14.60
-0.05
(-0.34%)
USD |
NASDAQ |
Dec 04, 14:02
Intellia Therapeutics Market Cap: 1.487B for Dec. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| December 03, 2024 | 1.492B |
| December 02, 2024 | 1.602B |
| November 29, 2024 | 1.591B |
| November 27, 2024 | 1.549B |
| November 26, 2024 | 1.500B |
| November 25, 2024 | 1.506B |
| November 22, 2024 | 1.456B |
| November 21, 2024 | 1.406B |
| November 20, 2024 | 1.336B |
| November 19, 2024 | 1.439B |
| November 18, 2024 | 1.443B |
| November 15, 2024 | 1.423B |
| November 14, 2024 | 1.540B |
| November 13, 2024 | 1.641B |
| November 12, 2024 | 1.696B |
| November 11, 2024 | 1.782B |
| November 08, 2024 | 1.704B |
| November 07, 2024 | 1.630B |
| November 06, 2024 | 1.636B |
| November 05, 2024 | 1.572B |
| November 04, 2024 | 1.542B |
| November 01, 2024 | 1.508B |
| October 31, 2024 | 1.448B |
| October 30, 2024 | 1.459B |
| October 29, 2024 | 1.526B |
| Date | Value |
|---|---|
| October 28, 2024 | 1.663B |
| October 25, 2024 | 1.624B |
| October 24, 2024 | 1.613B |
| October 23, 2024 | 2.030B |
| October 22, 2024 | 2.146B |
| October 21, 2024 | 2.104B |
| October 18, 2024 | 2.146B |
| October 17, 2024 | 2.136B |
| October 16, 2024 | 2.095B |
| October 15, 2024 | 1.987B |
| October 14, 2024 | 1.986B |
| October 11, 2024 | 1.891B |
| October 10, 2024 | 1.811B |
| October 09, 2024 | 1.797B |
| October 08, 2024 | 1.821B |
| October 07, 2024 | 1.816B |
| October 04, 2024 | 1.831B |
| October 03, 2024 | 1.797B |
| October 02, 2024 | 1.888B |
| October 01, 2024 | 1.954B |
| September 30, 2024 | 2.092B |
| September 27, 2024 | 2.133B |
| September 26, 2024 | 2.089B |
| September 25, 2024 | 2.102B |
| September 24, 2024 | 2.181B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
476.79M
Minimum
Mar 16 2020
12.99B
Maximum
Sep 03 2021
3.785B
Average
3.309B
Median
Feb 21 2023
Market Cap Benchmarks
| BridgeBio Pharma Inc | 5.197B |
| Alnylam Pharmaceuticals Inc | 32.77B |
| Ionis Pharmaceuticals Inc | 5.743B |
| Pfizer Inc | 142.84B |
| Regeneron Pharmaceuticals Inc | 82.36B |
Market Cap Related Metrics
| PS Ratio | 32.53 |
| PEG Ratio | -1.595 |
| Price to Book Value | 1.545 |
| Price | 14.60 |
| Earnings Yield | -37.26% |
| PEGY Ratio | -1.595 |